---











**MedXLink, Corp.**

378 North Main, #124; Layton, UT 84041

Registrant's telephone number including area code						(801) 497-9075



Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section
13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter
period that the registrant was required to file such reports)

Yes X	No

Yes X	No



---



The condensed financial statements included herein have been prepared by the Company,
pursuant to the rules and regulations of the Securities and Exchange Commission.

In the opinion of the Company, all adjustments, consisting of only normal recurring
adjustments, necessary to present fairly the financial position of the Company as of March 31, 2003
and the results of its operations and changes in its financial position from September 30, 2002
through March 31, 2003 have been made.  The results of its operations for such interim period is not
necessarily indicative of the results to be expected for the entire year.

---





(Unaudited)

|                                                                                                        | March 31,


2003 | September 30,


2002
|------------------------------------------------------------------------------------------------------- | ---------------- | --------------------
|**Assets**                                                                                             
|Current Assets                                                                                          |                  |                     
|Cash                                                                                                    | $	253            | $	63                
|Interest Receivable                                                                                     | 11,189           | 3,391               
|Note Receivable                                                                                         | 195,000          | 195,000             
|Total Assets                                                                                            | $	206,442        | $	198,454           
|                                                                                                        |                  |                     
|**Liabilities and Stockholders' Equity**                                                               
|Current Liabilities                                                                                     |                  |                     
|Accounts Payable                                                                                        | $	10,507         | $	79,627            
|Taxes Payable                                                                                           | 3,200            | 2,400               
|Interest Payable                                                                                        | 17,998           | 7,271               
|Notes Payable                                                                                           | 293,010          | 220,010             
|Total Current Liabilities                                                                               | 324,715          | 309,308             
|                                                                                                        |                  |                     
|Stockholders' Equity                                                                                    |                  |                     
|Common Stock; 100,000,000 Shares Authorized at $.001
Par Value; 2,256,594 Shares Issued and Outstanding | 2,257            | 2,257               
|Additional Paid in Capital                                                                              | 293,885          | 293,885             
|Retained Deficit                                                                                        | (414,415)        | (406,996)           
|                                                                                                        |                  |                     
|Total Stockholders' Equity                                                                              | (118,273)        | (110,854)           
|Total Liabilities and Stockholders' Equity                                                              | $	206,442        | $	198,454           

---



**MedXLink, Corp.**

(Unaudited)

|                                     | For the Three Months Ended | For the Six Months Ended
|------------------------------------ | -------------------------- | ------------------------
|                                     | March 31,


2003           | March 31,


2002        
|Revenue                              | $-                         | $-                      
|                                     |                            |                         
|Expenses                             |                            |                         
|General & Administrative             | 3,690                      | 2,988                   
|Total Expenses                       | 3,690                      | 2,988                   
|Loss from Operations                 | (3,690)                    | (2,988)                 
|                                     |                            |                         
|Other Income (Expenses)              |                            |                         
|Interest Income                      | 3,900                      | -                       
|Interest Expense                     | (6,242)                    | (103)                   
|Total Other Income

(Expenses)       | (2,342)                    | (103)                   
|Net Income (Loss)

- Before Taxes    | (6,032)                    | (3,091)                 
|Taxes                                | -                          | 800                     
|Net Income (Loss)                    | $	(6,032)                  | $	(3,891)               
|                                     |                            |                         
|Loss per Common Share                | $-                         | $-                      
|Weighted Average

Outstanding Shares | 2,256,594                  | 25,000,000              

---

******MedXLink, Corp.**Statement of Cash Flows
(Unaudited)

|                                                 | For the Six Months Ended
|------------------------------------------------ | ------------------------
|                                                 | March 31,


2003        
|Cash Flows from Operating Activities             |                         
|Net Income (Loss)                                | $	(7,716)               
|Adjustments to Reconcile Net (Loss) to Net Cash; |                         
|Increase in Interest Receivable                  | (7,800)                 
|Increase in Interest Payable                     | 11,026                  
|Increase in Taxes Payable                        | 800                     
|Increase in Accounts Payable                     | (69,120)                
|Net Cash Provided (Used) by Operating Activities | (72,810)                
|Cash Flows from Investing Activities             |                         
|(Increase) in Note Receivable                    | -                       
|Net Cash Provided (Used) by Investing Activities | -                       
|Cash Flows from Financing Activities             |                         
|Increase in Notes Payable                        | 73,000                  
|Net Cash Provided (Used) by Financing Activities | 73,000                  
|Increase (Decrease) in Cash                      | 190                     
|Cash, Beginning of Period                        | 63                      
|Cash, End of Period                              | $
	253                  
|Supplemental Cash Flow Information               |                         
|Interest                                         | $-                      
|Income Taxes (Including Penalties & Interest)    | -                       

---







NOTE 1 - Interim Financial Statements

The financial statements for the six months ended March 31, 2003 were prepared from the books and records
of the company.  Management believes that all adjustments have been made to the financial statements to
make a fair presentation of the financial condition of the company as of March 31, 2003.  The results of the
six months are not indicative of a full year of operation for the Company.

Certain information and footnote disclosures normally included in financial statements prepared in
accordance with generally accepted accounting principles, in the United States of America, have been
condensed or omitted.  It is suggested that these financial statements be read in conjunction with the
financial statements and notes thereto included in the Company's September 30, 2002 audited financial
statements.  The results of operations for the periods ended March 31, 2003 are not necessarily indicative
of the operating results for the full year.

**ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS.**

Liquidity and Capital Resources.  The Registrant had approximately $(118,273) as operating capital
at March 31, 2003, compared to $(29,846) for the same period last year. The Registrant intends to raise
additional funds as needed through private placements with accredited and sophisticated investors.

During the fourth fiscal quarter the Company entered into an agreement to acquire all of the equity
of eHDL, Inc.  Closing of the acquisition would  not take place, if at all, until certain events have occurred.
In anticipation of completing the acquisition, the Company sold $195,000 in convertible debentures at an
interest rate of 8% a.p.r. and due one year from date of issue to eHDL investors.  The Company loaned all
of the debenture proceeds to eHDL in an 8% a.p.r. promissory note due on demand and eHDL has agreed
to indemnify the Company from any financial responsibility of the debentures.  It is unclear at this time
whether the Company will have to repay the debentures or honor a conversions due to the lack of eHDL's
ability to perform on its guarantee.  In planning for its short term capital needs, the Company assumes that
it will not have to repay the debentures.  Should that change, the Company may have to seek bankruptcy
protection.

Results of Operation.  Due to the lack of operations during the quarter ended March 31, 2003, the
registrant had a net loss of $(6,032) compared to a net loss of $(3,891) for the same period last year.

Plan of Operations.  The Company is currently in the process of looking for business opportunities
to acquire or merge with.  There is no guarantee that management will be successful in finding such an
opportunity.  During this process, the Company intends to raise operational capital through private
placements.

---

**ITEM 3 - CONTROLS AND PROCEDURES.**

(a) Evaluation of disclosure controls and procedures.  The Company's principal executive officer and
its principal financial officer, based on their evaluation of the Company's disclosure controls and procedures
(as defined in Exchange Act Rules 13a-14 (c) as of a date within 90 days prior to the filing of this Quarterly
Report on Form 10-QSB, have concluded that the Company's disclosure controls and procedures are
adequate and effective for the purposes set forth in the definition in Exchange Act rules.

(b) Changes in internal controls.  There were no significant changes in the Company's internal
controls or in other factors that could significantly affect the Company's internal controls subsequent to the
date of their evaluation.

---

**OTHER INFORMATION**

Item 1.	Legal Proceedings	None

Item 2.	Changes in Securities	None

Item 3.	Defaults Upon Senior Securities	None

Item 4.	Submission of Matters to a Vote of Security Holders	None

Item 5.	Other Information	None

Item 6.	Exhibits and Reports on Form 8-K	None

---



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned authorized officer.

Dated: May 8, 2003	**MedXLink, Corp.**

/S/ Dean BeckerDean Becker

---



**SECTION 302 CERTIFICATION**

I, Dean Becker, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of MedXLink, Corp;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this quarterly
report.

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a) Designed such disclosure controls and procedures to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this quarterly report is being prepared.

b) Evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date
within 90 days prior to the filing date of this quarterly report (the "Evaluation Date"); and

c) Presented in this quarterly report our conclusions about the effectiveness
of the disclosure controls
and procedures based on our evaluation as of the Evaluation Date;

5. I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit
committee of registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies in the design or operation of internal controls which could adversely
affect the registrant's ability to record, process, summarize and report financial data and have
identified for the registrant's auditors any material weaknesses in internal controls; and

b) Any fraud, whether or not material, that involves management or other employees who have a
significant role in the registrant's internal controls; and

6.  I have indicated in this quarterly report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal controls subsequent to the date of our most
recent evaluation, including any corrective actions with regard to significant deficiencies and material
weaknesses.

Date: May 8, 2003	/s/Dean Becker
Chief Executive Officer And Principle Accounting Officer

---



In connection with the Quarterly Report of MedXLink, Corp, on Form 10-QSB for the period ending
March 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the *"Report"*),
the undersigned, Dean Becker, Chief Executive Officer and Principle Accounting Officer  of the Company,
certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13 (a) or 15 (d) of the Securities
Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial
condition and result of operations of the Company.

Date: May 8, 2003

Dean Becker,
Chief Executive Officer
And Principle Accounting Officer

---